Compare COCH & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COCH | MLSS |
|---|---|---|
| Founded | 1995 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.0M | 42.6M |
| IPO Year | 2021 | 1996 |
| Metric | COCH | MLSS |
|---|---|---|
| Price | $0.70 | $0.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $6.00 | $1.00 |
| AVG Volume (30 Days) | 50.5K | ★ 60.7K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.45 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $241,000.00 | ★ $8,973,982.00 |
| Revenue This Year | $1.58 | $12.64 |
| Revenue Next Year | N/A | $8.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 7.11 | 3.99 |
| 52 Week Low | $0.36 | $0.22 |
| 52 Week High | $1.89 | $0.60 |
| Indicator | COCH | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 46.24 | 46.07 |
| Support Level | $0.63 | $0.38 |
| Resistance Level | $0.74 | $0.44 |
| Average True Range (ATR) | 0.03 | 0.04 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 32.11 | 37.95 |
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.